Therapeutic depletion of natural killer cells controls persistent infection.
about
Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cellsRecognition and Regulation of T Cells by NK CellsNK Cells in HIV DiseaseCrosstalk between innate and adaptive immunity in hepatitis B virus infectionNK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinomaBoosting vaccine efficacy the natural (killer) wayAnti-asialo GM1 NK cell depleting antibody does not alter the development of bleomycin induced pulmonary fibrosis.Immune control and failure in HCV infection--tipping the balance.NK cells and their ability to modulate T cells during virus infectionsType I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.T cell exhaustion during persistent viral infections.Gut microbiota modulate the immune effect against hepatitis B virus infection.NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditionsNK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infectionRoles of natural killer cells in antiviral immunityImmunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses.T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.Type I interferon: understanding its role in HIV pathogenesis and therapy.Understanding Experimental LCMV Infection of Mice: The Role of Mathematical Models.Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function.Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.NK cells in host responses to viral infections.Irreversible splenic atrophy following chronic LCMV infection is associated with compromised immunity in mice.Innate and Adaptive Immune Responses in Chronic HCV Infection.Circulating NK cells and their subsets in Behçet's disease.The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection.Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.Bacterial coinfection restrains antiviral CD8 T-cell response via LPS-induced inhibitory NK cells
P2860
Q26314406-E2421344-420D-455C-AA8C-8A4303F876F9Q26742166-94383878-B41E-436C-9C3D-55AB0C0F256DQ26752833-44491788-06E5-40BD-A829-B9CFAB3AE7B9Q26771142-CFAC2EA4-D854-440C-B137-2F10052E000AQ27001052-55E0177D-1E99-4C3F-BDD1-B015CB3D312FQ28084474-99191967-F93B-4107-8A1E-F3F713F6E22FQ33748545-1021EAF0-4E3B-4EAB-960E-EF5CE609093DQ34178628-D7A66500-581C-4AB1-B8AC-6967EF6E336DQ34700499-FACCD809-F406-4CF4-9634-8C65A25F0561Q35564886-3895509D-C667-46D9-BD3F-B589A3B74095Q35582265-50DAFE31-3BC8-452A-8F78-3BC60E10CB04Q35745517-A6F51898-212C-49E2-9368-121E6B3C7873Q36569520-EDB7A673-D92D-41A9-B9CB-A3B1FBACCFD6Q36608144-1EBEA3CD-7AC3-45C4-8B9F-CFEA5803C60FQ36767761-DA375744-AF33-4FCB-A665-09DD99603F66Q37337220-1E3C819F-1A50-41A3-9225-C28F3F8038DDQ37598020-DD4FDB6D-9636-4B60-A53E-53548326931FQ38348388-44B92219-D9A1-49FD-8ED2-4DAEC253A8C3Q38635743-BE41F9D3-2148-40D6-96F8-437D66ADD032Q38846135-83212E84-FA08-41EF-9CFD-F1AB824F3C7EQ38964920-D79E9188-D4EA-4777-8BC4-9E78BE4B0AD7Q39041518-6363CE7A-47C9-40DA-BF1D-B0AAB5F5F59CQ40468923-8726A3C8-ADD3-482B-A3A8-4130A1DD7CC5Q41035955-84512A7F-5BA1-43E6-97D7-142A2B3878CDQ42097602-07F4AEB9-1873-4D2A-A445-88ADECA0626EQ45324456-1D4650D5-754C-49DF-8088-CF90FDFB3C41Q52668670-BC02519C-F4B6-4553-A449-801DDE786E38Q54213151-9BA8B7F5-C4B0-4017-B534-D654811DC1F9Q54223897-F8D183BD-6D5C-465A-9F9C-C46FB2AFC5C0Q57295499-D6E7CAB1-B2D6-45D0-B692-907F70A3E6D1
P2860
Therapeutic depletion of natural killer cells controls persistent infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Therapeutic depletion of natural killer cells controls persistent infection.
@en
Therapeutic depletion of natural killer cells controls persistent infection.
@nl
type
label
Therapeutic depletion of natural killer cells controls persistent infection.
@en
Therapeutic depletion of natural killer cells controls persistent infection.
@nl
prefLabel
Therapeutic depletion of natural killer cells controls persistent infection.
@en
Therapeutic depletion of natural killer cells controls persistent infection.
@nl
P2860
P356
P1433
P1476
Therapeutic depletion of natural killer cells controls persistent infection
@en
P2093
Keith A Daniels
Raymond M Welsh
P2860
P304
P356
10.1128/JVI.03002-13
P407
P577
2013-11-27T00:00:00Z